NDC 69238-1345-05 - Albuterol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69238-1345
- Requested NDC
- 69238-1345-05
- Package NDCs from labels
- 69238-1345-1, 69238-1345-5, 69238-1345-05
- Manufacturer
- Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited
- Effective date
- 2026-04-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Albuterol Tablets, USP (2 mg and 4 mg) Rx only | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited | 2026-04-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69238-1345-1 | Albuterol | 100 in 1 BOTTLE | TABLET | 100 | 7 | |
| 69238-1345-5 | Albuterol | 500 in 1 BOTTLE | TABLET | 500 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69238-1345 | ALBUTEROL TABLET [AMNEAL PHARMACEUTICALS NY LLC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20241220_230d66fc-f62c-42a6-adb3-0a0f879c8ad4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69238-1345-1 | EA - Each | 69238-1345 | e73f277e-4294-4cb5-8048-55da25e57b2f | 1 | 2018-08-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Redpharm Drug | 594bb030-e6e5-1da4-e063-6394a90aba55 | 2026-08-18 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Armstrong Pharmaceuticals, Inc. | 17858afa-dcdf-4612-b475-3b6baadfb639 | 2026-08-06 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | NuCare Pharmaceuticals, Inc. | 583c6408-45cc-9121-e063-6294a90afcc4 | 2026-08-04 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Rising Pharma Holdings, Inc. | 3236f82c-14e9-dfd4-e063-6294a90ac43d | 2026-07-16 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Rising Pharma Holdings, Inc. | 3246dfab-61d7-27ba-e063-6294a90ac180 | 2026-07-16 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Rising Pharma Holdings, Inc. | 32377c09-da6d-331c-e063-6294a90a7a46 | 2026-07-16 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Rising Pharma Holdings, Inc | 32474c0e-af35-69d1-e063-6394a90a53c6 | 2026-07-16 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | HAWAII REPACK, INC. | b18fad6e-f117-4840-83b7-8c261c646af1 | 2026-07-03 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | American Health Packaging | 4aec7f59-b429-4b0e-a779-8df1dd8f80d7 | 2026-06-23 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Cipla USA Inc. | 3c64255e-074c-41f8-a344-3686a0685020 | 2026-06-22 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | REMEDYREPACK INC. | 0f9bf2c8-55c0-4b4d-97de-d6c7220c3862 | 2026-06-17 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | A-S Medication Solutions | 65504330-6c02-4e30-9f32-51393e06f20c | 2026-05-22 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Cipla USA Inc. | c4d6d76a-14b8-411a-8019-e2c923c2c532 | 2026-05-20 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | American Health Packaging | b0a5da99-6553-4088-ae27-7fa194438340 | 2026-05-20 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Preferred Pharmaceuticals Inc. | 66f32a06-c880-4b5b-837b-951e1e01e040 | 2026-05-13 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate Inhalation Solution, 0.5% | ALBUTEROL SULFATE | Ritedose Pharmaceuticals, LLC | fdb4ac5a-bf0d-4896-89f7-1828c081b79e | 2026-04-30 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate Inhalation Solution | ALBUTEROL SULFATE | Ritedose Pharmaceuticals, LLC | d4c532be-1f41-60d3-e053-2995a90a98be | 2026-04-30 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Ritedose Pharmaceuticals, LLC | b72742df-1a6b-4483-aff3-3e79db5e015d | 2026-04-30 | Warnings, Adverse reactions | 021SEF3731 |
| albuterol sulfate | ALBUTEROL SULFATE | Sportpharm LLC | 440a96bb-9e69-bdcc-e063-6294a90a6793 | 2026-04-24 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Sportpharm LLC | a33e20e0-3936-450d-a9d9-3ff51c6f26c5 | 2026-04-24 | Warnings, Adverse reactions | 021SEF3731 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.